A cutting-edge clinical research initiative

Ready to operate from 2021, ECRAID will be prepared to respond to infectious diseases that are of public health concern to Europe by carrying out cutting-edge research. ECRAID is a European-wide initiative that aims to establish a self-sustaining clinical research organisation and network for infectious diseases. The first of its kind, ECRAID will bring together clinical research in emerging infectious diseases with antimicrobial resistance. 

A cutting-edge clinical research initiative

Over the next two years...

Over the next two years...

ECRAID will develop a business plan in line with European-funded networks to create a clinical research infrastructure that will operate from 2021. This business plan is called ECRAID-Plan. 

It is working with the network partners and Monitor Deloitte to develop a business plan. The business plan will outline ECRAID services, operations,  governance structure, and financial sustainability plans. 

ECRAID is seeking to strengthen alliances with the private sector and international organisations involved in infectious disease interventions to boost investments into protecting European public health. 

Keep up to date with developments in ECRAID-Plan by following the latest news. 

Latest News

Purpose & Vision of ECRAID

Our Purpose

Our Purpose

Our purpose is to reduce the impact of infectious diseases on individual and population health.

Our Vision

Our Vision

Our vision is to efficiently generate rigorous evidence to improve the diagnosis, prevention and treatment of infections and to better respond to infectious disease threats. This is facilitated by a European multidisciplinary clinical research network and innovative research approaches.